28,490 resources
By Version
By Authority
By Realm
Start Prev Rows 3400 - 3600 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) |
---|---|---|---|---|---|---|---|---|---|---|
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.34 | Prediabetes Oral Glucose Tolerance Tests | active | 2023-01 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.35 | Prediabetes Oral Glucose Tolerance Tests | active | 2023-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.36 | Prediabetes Fasting plasma glucose or Plasma Glucose Tests | active | 2023-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.37 | Prediabetes Fasting plasma glucose or Plasma Glucose Tests | active | 2023-01 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.38 | Prediabetes Fasting plasma glucose or Plasma Glucose Tests | active | 2023-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.4 | Glycemic Screening Tests | active | 2025-03 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.40 | Sickle Cell Disease with Vaso Occlusive Episode | active | 2024-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.41 | Sickle Cell Disease with Vaso Occlusive Episode | active | 2024-05 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.42 | Sickle Cell Disease with Vaso Occlusive Episode | active | 2024-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.43 | Analgesics for Acute Pain | active | 2025-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.49 | Medication Therapy Management Services for Essential Hypertension | active | 2024-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.5 | Glycemic Screening Tests | active | 2023-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.52 | Remote Physiologic Blood Pressure Monitoring | active | 2024-10 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.57 | Aldosterone Receptor Blocker for Hypertension | active | 2024-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.58 | Alpha Blocker for Hypertension | active | 2024-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.59 | Angiotensin Converting Enzyme Inhibitor for Hypertension | active | 2024-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.6 | Glycemic Screening Tests | active | 2023-01 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.60 | Angiotensin II Receptor Blocker for Hypertension | active | 2024-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.61 | Beta Blocker for Hypertension | active | 2024-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.62 | Calcium Channel Blocker Dihydropyridine for Hypertension | active | 2024-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.63 | Calcium Channel Blocker Non Dihydropyridine for Hypertension | active | 2024-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.64 | Central Acting for Hypertension | active | 2024-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.65 | Direct Renin Inhibitor for Hypertension | active | 2024-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.66 | Loop Diuretic for Hypertension | active | 2024-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.67 | Neuronal Blocking Agent for Hypertension | active | 2024-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.68 | Potassium Sparing Diuretic for Hypertension | active | 2024-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.69 | Thiazide Diuretic for Hypertension | active | 2024-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.7 | Preventative Clinical Encounters | active | 2025-03 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.70 | Vasodilator for Hypertension | active | 2024-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.73 | Analgesics for Acute Pain (Non Parenteral Route) | active | 2025-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.74 | Analgesics for Acute Pain (Parenteral Route) | active | 2025-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.75 | Analgesics for Acute Pain Non Oral Enteral/Mucosal Routes | active | 2024-11 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.77 | Antihypertensive Medication Classes | active | 2024-10 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.78 | Medication Therapy Management Services for Essential Hypertension | active | 2024-10 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.79 | Medication Therapy Management Services for Essential Hypertension | active | 2024-10 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.8 | Preventative Clinical Encounters | active | 2025-03 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.84 | Renal Colic | active | 2025-04 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.85 | Renal Colic | active | 2025-04 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.86 | Renal Colic | active | 2025-04 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.88 | Direct LDL Cholesterol | active | 2025-05 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.89 | Calculated LDL Cholesterol | active | 2025-05 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1160.9 | Preventative Clinical Encounters | active | 2025-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1164.50 | Urinary retention | active | 2017-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1164.51 | Urinary retention | active | 2017-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1164.52 | Urinary retention | active | 2017-06 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1164.65 | Morbid Obesity | active | 2018-04 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1164.66 | Morbid Obesity | active | 2018-04 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1164.67 | Morbid Obesity | active | 2018-04 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1164.68 | BMI greater than 40 | active | 2019-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1164.69 | Morbid Obesity | active | 2019-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.141 | Contraceptive Patch SNOMED Devices | active | 2021-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.143 | Live Birth Delivery CPT Procedures | active | 2024-09 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.144 | Contraceptive Patch SNOMED Provision Procedures | active | 2021-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.145 | Contraceptive Patch SNOMED Findings | active | 2021-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.146 | Contraceptive Patch ICD10CM Provision Encounters | active | 2021-10 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.147 | Contraceptive Patch ICD10CM Surveillance | active | 2021-10 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.148 | Live Birth Delivery ICD10PCS Procedures | active | 2024-09 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.149 | Contraceptive Patch HCPCS Devices | active | 2021-10 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.15 | Chlamydia trachomatis and Neisseria Gonorrhoeae combined Tests | active | 2025-03 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.150 | Contraceptive Patch LOINC | active | 2021-10 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.152 | Live Birth Delivery Procedures SNOMED CT | active | 2024-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.153 | Contraceptive Ring SNOMED Surveillance Procedures | active | 2021-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.154 | Contraceptive Ring SNOMED Provision Procedures | active | 2021-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.155 | Contraceptive Ring SNOMED Findings | active | 2021-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.156 | Contraceptive Ring ICD10CM Provision Encounters | active | 2021-10 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.157 | Contraceptive Ring ICD10CM Surveillance | active | 2021-10 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.159 | Contraceptive Ring HCPCS Devices | active | 2022-01 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.160 | Contraceptive Ring LOINC | active | 2021-10 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.161 | Contraceptive Implant SNOMED Devices | active | 2021-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.162 | Contraceptive Implant ICD10PCS Provision Procedures | active | 2021-10 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.163 | Contraceptive Implant SNOMED Provision Procedures | active | 2021-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.164 | Contraceptive Implant SNOMED Findings | active | 2021-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.170 | Contraceptive Implant ICD10CM Provision Encounters | active | 2021-10 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.171 | Contraceptive Implant ICD10CM Surveillance | active | 2021-10 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.173 | Contraceptive Implant HCPCS Devices | active | 2021-10 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.174 | Contraceptive Patch Devices | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.177 | Live Birth Delivery Procedures | active | 2024-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.178 | Contraceptive Ring Surveillance | active | 2021-10 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.180 | Contraceptive Implant CPT Provision Procedures | active | 2021-10 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.181 | Injectable Contraceptive SNOMED Surveillance Procedures | active | 2021-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.182 | Injectable Contraceptive SNOMED Provision Procedures | active | 2021-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.183 | Injectable Contraceptive SNOMED Findings | active | 2021-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.185 | Injectable Contraceptive ICD10CM Provision Encounters | active | 2021-10 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.186 | Injectable Contraceptive ICD10CM Surveillance | active | 2021-10 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.187 | Injectable Contraceptive HCPCS Provision Procedures | active | 2021-10 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.188 | Injectable Contraceptive LOINC | active | 2021-10 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.189 | Oral Contraceptive Pill SNOMED Surveillance Procedures | active | 2021-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.190 | Oral Contraceptive Pill SNOMED Provision Procedures | active | 2021-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.191 | Oral Contraceptive Pill SNOMED Findings | active | 2021-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.193 | Oral Contraceptive Pill ICD10CM Provision Encounters | active | 2021-10 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.194 | Oral Contraceptive Pill ICD10CM Surveillance | active | 2021-10 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.195 | Oral Contraceptive Pill HCPCS Provision Procedures | active | 2021-10 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.196 | Oral Contraceptive Pill LOINC | active | 2021-10 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.197 | Injectable Contraceptive Provision Procedures | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.198 | Injectable Contraceptive Surveillance | active | 2021-10 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.199 | Oral Contraceptive Pill Provision Procedures | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.200 | Oral Contraceptive Pill Surveillance | active | 2021-10 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.201 | Contraceptive Implant Devices | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.202 | Contraceptive Implant Provision Procedures | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.203 | Contraceptive Implant Surveillance | active | 2021-10 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.96 | Infecund Not for Contraceptive Reasons SNOMED Findings | active | 2021-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.10 | ASN Screening Declined | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.2 | Intracranial or Intraspinal surgery | active | 2022-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.22 | Emergency Department Observation | active | 2024-09 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.27 | Mental Health Diagnosis without Substance Use Disorders | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.28 | Mental Health Diagnosis without Substance Use Disorders | active | 2025-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.29 | Bed Assigned | active | 2024-05 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.3 | Malignant Intracranial Neoplasm Group | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.31 | Healthcare Agent & Power of Attorney Documentation | active | 2024-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.32 | Healthcare Agent and Power of Attorney Documentation | active | 2024-09 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.33 | Advance Directive Documentation | active | 2024-10 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.34 | Advance Directive Documentation | active | 2024-11 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.35 | Advance Directive Documentation | active | 2024-09 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.36 | Portable Medical Order(s) Documentation | active | 2024-10 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.37 | Portable Medical Order(s) Documentation | active | 2024-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.38 | Advance Care Planning Discussion Documentation | active | 2024-11 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.4 | Thrombolytic medications | active | 2021-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.40 | Advance Care Planning Documentation | active | 2024-09 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.41 | Advance Care Planning Documentation | active | 2024-09 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.42 | Healthcare Agent & Power of Attorney Documentation | active | 2024-10 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.43 | Advance Directive Documentation | active | 2024-10 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.45 | Advance Care Planning Documentation | active | 2024-11 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.46 | Advance Care Planning Documentation | active | 2024-10 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.47 | Portable Medical Order(s) Documentation | active | 2024-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.48 | Portable Medical Order(s) Documentation | active | 2024-10 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.49 | Intervention for Positive Utility Insecurity Screen | active | 2024-11 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.5 | Allergy to thrombolytics | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.50 | Intervention for Positive Utility Insecurity Screen | active | 2024-11 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.51 | Intervention for Positive Transportation Insecurity Screen | active | 2024-11 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.52 | Intervention for Positive Transportation Insecurity Screen | active | 2024-11 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.53 | Intervention for Positive Housing Instability Screen | active | 2024-11 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.54 | Intervention for Positive Housing Instability Screen | active | 2024-11 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.55 | Intervention for Positive Homelessness Screen | active | 2024-11 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.56 | Intervention for Positive Homelessness Screen | active | 2024-11 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.57 | Non Invasive Oxygen Therapy Device Codes | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.58 | Goals, preferences, and priorities for medical treatment | active | 2025-04 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.6 | Thrombolytics Adverse Event | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1170.7 | Intraspinal surgery | active | 2024-02 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1176.58 | Food Insecurity Screening Positive | active | 2023-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.1 | Ezetimibe Therapy | active | 2023-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.10 | Antihypertensive Medications | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.100 | Allergy or Intolerance to ACE Medication | active | 2024-11 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.101 | Allergy or Intolerance to ARB Medication | active | 2024-11 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.102 | Chronic Kidney Disease Stage 1 | active | 2024-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.103 | Chronic Kidney Disease Stage 2 | active | 2024-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.104 | Chronic Kidney Disease Stage 3 | active | 2024-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.105 | Chronic Kidney Disease Stage 4 | active | 2024-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.106 | Chronic Kidney Disease Stage 5 | active | 2024-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.107 | ICD10 CM Chronic Kidney Disease Stage 1 | active | 2024-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.108 | ICD10 CM Chronic Kidney Disease Stage 2 | active | 2024-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.111 | AHA GWTG Chronic Kidney Disease Stage 2 | active | 2024-11 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.112 | ICD10 CM Chronic Kidney Disease Stage 3 | active | 2024-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.113 | ICD10 CM Chronic Kidney Disease Stage 4 | active | 2024-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.114 | ICD10 CM Chronic Kidney Disease Stage 5 | active | 2024-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.115 | AHA GWTG Chronic Kidney Disease Stage 1 | active | 2024-11 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.116 | AHA GWTG Chronic Kidney Disease Stage 3 | active | 2024-11 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.117 | AHA GWTG Chronic Kidney Disease Stage 4 | active | 2024-11 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.118 | SNOMED CT Atrial Fibrillation | active | 2024-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.119 | ICD10 CM Atrial Fibrillation | active | 2024-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.121 | AHA GWTG Atrial Fibrillation | active | 2024-11 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.123 | SNOMED CT Hyperlipidemia | active | 2024-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.124 | ICD10 CM Hyperlipidemia | active | 2024-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.125 | AHA GWTG Hyperlipidemia | active | 2024-11 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.126 | SNOMED CT Hypertriglyceridemia | active | 2024-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.127 | ICD10 CM Hypertriglyceridemia | active | 2024-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.129 | AHA GWTG Hypertriglyceridemia | active | 2024-11 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.130 | SNOMED CT Gestational Diabetes | active | 2024-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.131 | ICD10 CM Gestational Diabetes | active | 2024-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.132 | AHA GWTG Gestational Diabetes | active | 2024-11 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.133 | SNOMED CT Hyperglycemia | active | 2024-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.134 | ICD10 CM Hyperglycemia | active | 2024-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.135 | AHA GWTG Hyperglycemia | active | 2024-11 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.136 | SNOMED CT Nonobstructive CAD | active | 2024-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.137 | ICD10 CM Nonobstructive Coronary Artery Disease | active | 2024-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.138 | AHA GWTG Nonobstructive coronary artery disease | active | 2024-11 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.139 | AHA GWTG Anti Obesity Pharmacotherapy | active | 2024-12 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.15 | Non Tobacco Smoking Product User | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.16 | Antihypertensive Fixed Dose Combination Medications | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.2 | PCSK9 Inhibitors | active | 2023-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.20 | CCB and Thiazide and Thiazide Like Diuretics | active | 2021-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.21 | Referral to cardiac rehab | active | 2021-04 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.22 | Cardiac Rehabilitation | active | 2021-04 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.25 | 2 Hour Blood Glucose Test | active | 2022-07 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.26 | NYHA Functional Classification | active | 2022-07 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.27 | ARNI Therapy | active | 2022-07 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.29 | MRA Therapy | active | 2022-07 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.3 | Cholesterol non HDL Laboratory Test | active | 2021-04 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.30 | SGLT2 Inhibitors | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.31 | Heart Transplant | active | 2022-02 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.32 | Heart Transplant | active | 2022-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.33 | Heart Transplant | active | 2022-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.34 | Allergy to MRA Therapy | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.35 | Aspirin or Clopidogrel | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.39 | Cardiac Rehabilitation | active | 2024-01 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.4 | Hypothyroidism | active | 2021-04 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.40 | Cardiac Rehabilitation | active | 2022-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.43 | SGLT2 Ingredients | active | 2022-07 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.44 | MRA Ingredients | active | 2022-07 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.49 | Minnesota Living with Heart Failure Questionnaire | active | 2022-07 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1178.5 | Hypothyroidism | active | 2024-02 | us | hl7 | sct |